Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Mimedx Group (MDXG) Return on Capital Employed: 2011-2025

Historic Return on Capital Employed for Mimedx Group (MDXG) over the last 13 years, with Sep 2025 value amounting to 0.22%.

  • Mimedx Group's Return on Capital Employed fell 11.00% to 0.22% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.22%, marking a year-over-year decrease of 11.00%. This contributed to the annual value of 0.29% for FY2024, which is 5.00% up from last year.
  • Latest data reveals that Mimedx Group reported Return on Capital Employed of 0.22% as of Q3 2025, which was up 17.16% from 0.19% recorded in Q2 2025.
  • Over the past 5 years, Mimedx Group's Return on Capital Employed peaked at 0.34% during Q2 2024, and registered a low of -0.27% during Q1 2021.
  • In the last 3 years, Mimedx Group's Return on Capital Employed had a median value of 0.24% in 2023 and averaged 0.22%.
  • As far as peak fluctuations go, Mimedx Group's Return on Capital Employed spiked by 44bps in 2023, and later fell by 15bps in 2025.
  • Over the past 5 years, Mimedx Group's Return on Capital Employed (Quarterly) stood at -0.05% in 2021, then declined by 6bps to -0.11% in 2022, then skyrocketed by 34bps to 0.22% in 2023, then increased by 6bps to 0.28% in 2024, then decreased by 11bps to 0.22% in 2025.
  • Its Return on Capital Employed was 0.22% in Q3 2025, compared to 0.19% in Q2 2025 and 0.24% in Q1 2025.